109 related articles for article (PubMed ID: 35482141)
1. Functional network analysis of p85 and PI3K as potential gene targets and mechanism of oleanolic acid in overcoming breast cancer resistance to tamoxifen.
Ibadurrahman W; Hanif N; Hermawan A
J Genet Eng Biotechnol; 2022 Apr; 20(1):66. PubMed ID: 35482141
[TBL] [Abstract][Full Text] [Related]
2. MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis.
Azzahra SNA; Hanif N; Hermawan A
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2341-2350. PubMed ID: 35901340
[TBL] [Abstract][Full Text] [Related]
3. Genomic Understanding Reveals the Important Role of FGFR2 as Paeoniflorin Target for Circumventing Breast Cancer Resistance to Tamoxifen.
Wibowo MA; Nugroho EP; Hermawan A
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3949-3958. PubMed ID: 34967576
[TBL] [Abstract][Full Text] [Related]
4. Identification of key genes involved in tamoxifen-resistant breast cancer using bioinformatics analysis.
Wang X; Wang S
Transl Cancer Res; 2021 Dec; 10(12):5246-5257. PubMed ID: 35116374
[TBL] [Abstract][Full Text] [Related]
5. Identification of Ten Mitosis Genes Associated with Tamoxifen Resistance in Breast Cancer.
Sun X; Ding S; Lu S; Wang Z; Chen X; Shen K
Onco Targets Ther; 2021; 14():3611-3624. PubMed ID: 34113127
[TBL] [Abstract][Full Text] [Related]
6. Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer.
Wang Y; Gong X; Zhang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34406386
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy.
Zhu QN; Renaud H; Guo Y
Hereditas; 2018; 155():17. PubMed ID: 29371858
[TBL] [Abstract][Full Text] [Related]
8. Identification of the Significant Genes Regulated by Estrogen Receptor in Estrogen Receptor-Positive Breast Cancer and Their Expression Pattern Changes When Tamoxifen or Fulvestrant Resistance Occurs.
Cheng R; Qi L; Kong X; Wang Z; Fang Y; Wang J
Front Genet; 2020; 11():538734. PubMed ID: 33133141
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen.
Hermawan A; Putri H; Hanif N; Fatimah N; Prasetio HH
Front Oncol; 2022; 12():1019025. PubMed ID: 36601474
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.
Mishra RR; Belder N; Ansari SA; Kayhan M; Bal H; Raza U; Ersan PG; Tokat ÜM; Eyüpoğlu E; Saatci Ö; Jandaghi P; Wiemann S; Üner A; Cekic C; Riazalhosseini Y; Şahin Ö
Clin Cancer Res; 2018 Apr; 24(8):1987-2001. PubMed ID: 29386221
[No Abstract] [Full Text] [Related]
11. Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells.
Cun J; Yang Q
Biomed Pharmacother; 2018 Nov; 107():117-128. PubMed ID: 30086458
[TBL] [Abstract][Full Text] [Related]
12. The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining.
Xu D; Zhang Y; Jin F
BMC Cancer; 2021 Dec; 21(1):1321. PubMed ID: 34886806
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer.
Zhang K; Jiang K; Hong R; Xu F; Xia W; Qin G; Lee K; Zheng Q; Lu Q; Zhai Q; Wang S
PeerJ; 2020; 8():e10468. PubMed ID: 33335811
[TBL] [Abstract][Full Text] [Related]
14. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
Tang D; Zhao X; Zhang L; Wang Z; Wang C
J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
[TBL] [Abstract][Full Text] [Related]
15. Overcoming tamoxifen resistance in oestrogen receptor-positive breast cancer using the novel thiosemicarbazone anti-cancer agent, DpC.
Maqbool SN; Lim SC; Park KC; Hanif R; Richardson DR; Jansson PJ; Kovacevic Z
Br J Pharmacol; 2020 May; 177(10):2365-2380. PubMed ID: 31975484
[TBL] [Abstract][Full Text] [Related]
16. Multi-time scale transcriptomic analysis on the dynamic process of tamoxifen resistance development in breast cancer cell lines.
Zeng Q; Lin X; Chen H; Yan Y; Wang X
Breast Cancer; 2022 May; 29(3):458-467. PubMed ID: 35041152
[TBL] [Abstract][Full Text] [Related]
17. Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.
Fu X; Creighton CJ; Biswal NC; Kumar V; Shea M; Herrera S; Contreras A; Gutierrez C; Wang T; Nanda S; Giuliano M; Morrison G; Nardone A; Karlin KL; Westbrook TF; Heiser LM; Anur P; Spellman P; Guichard SM; Smith PD; Davies BR; Klinowska T; Lee AV; Mills GB; Rimawi MF; Hilsenbeck SG; Gray JW; Joshi A; Osborne CK; Schiff R
Breast Cancer Res; 2014 Sep; 16(5):430. PubMed ID: 25212826
[TBL] [Abstract][Full Text] [Related]
18. Network Pharmacology-Based Analysis on the Action Mechanism of Oleanolic Acid to Alleviate Osteoporosis.
Wu Y; Gao LJ; Fan YS; Chen Y; Li Q
ACS Omega; 2021 Oct; 6(42):28410-28420. PubMed ID: 34723038
[TBL] [Abstract][Full Text] [Related]
19. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
[TBL] [Abstract][Full Text] [Related]
20. Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.
Cao L; Chen Y; Zhang M; Xu DQ; Liu Y; Liu T; Liu SX; Wang P
PeerJ; 2018; 6():e5180. PubMed ID: 30002985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
